The 'common deletion' is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction

Movement Disorders

Volumn 12, Issue 5, 1997, Pages 639-645

  Kösel, Siegfried ^a   Egensperger, Rupert ^a   Schnopp, Nina M ^a   Graeber, Manuel B ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Institute of Neuropathology   (Germany)

Author keywords

'Common deletion,' 4,977 base pair; Genotype phenotype analysis; Image analysis; Neuropathology; Susceptibility genes

Indexed keywords

GLUTAMINE; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TRANSFER RNA;

ADULT; AGED; ALLELE; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LEWY BODY; MALE; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PARKINSONISM; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY CHAIN; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP2D6; DISEASE SUSCEPTIBILITY; DNA, MITOCHONDRIAL; FEMALE; GENE DELETION; GENOTYPE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); PARKINSON DISEASE; POINT MUTATION; POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA;

EID: 0030931581     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120504     Document Type: Article

References (14)

1. Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989;i:1269.
2. Mizuno Y, Ohta S, Tanaka M, et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989;163:1450-1455.
3. Shoffner JM, Watts RL, Juncos JL, Torroni A, Wallace DC. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 1991;30:332-339.
4. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983;219:979-980.
5. 1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 1990;55:2142-2145.
6. Mann VM, Cooper JM, Schapira AHV. Quantitation of mitochondrial DNA deletion in Parkinson's disease. FEES Lett 1992;299: 218-222.
7. Janetzky B, Hauck S, Youdim MBH, et al. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett 1994; 169:126-128.
8. Johnson WG, Hodge SE, Duvoisin R. Twin studies and the genetics of Parkinson's disease: a reappraisal. Mov Disord 1990;5:187-194.
9. Johnson WG. Genetic susceptibility to Parkinson's disease. Geriatrics 1991;46:52-59.
10. Ikebe S, Tanaka M, Ozawa T. Point mutations of mitochondrial genome in Parkinson's disease. Mol Brain Res 1995;28:281-295.
11. Kösel S, Lücking CB, Egensperger R, Mehraein P, Graeber MB. Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy-body parkinsonism. J Neurosci Res 1996;44:174-183.
12. Wallace DC. Diseases of the mitochondrial DNA. Annu Rev Biochem 1992;61:1175-1212.
13. Cortopassi GA, Shibata D, Soong NW, Arnheim N. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc Natl Acad Sci USA 1992;89:7370-7374.
14. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genet 1992;2:324-329.